We are live on ! Find out more
BHC icon

Bausch Health

211 hedge funds and large institutions have $2.09B invested in Bausch Health in 2024 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 46 increasing their positions, 70 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more funds holding in top 10

Funds holding in top 10: 78 (+1)

6% more capital invested

Capital invested by funds: $1.96B → $2.09B (+$125M)

7.06% less ownership

Funds ownership: 76.65%69.59% (-7.1%)

10% less funds holding

Funds holding: 234211 (-23)

34% less repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 70

47% less first-time investments, than exits

New positions opened: 26 | Existing positions closed: 49

71% less call options, than puts

Call options by funds: $41.8M | Put options by funds: $146M

Holders
211
Holders Change
-23
Holders Change %
-9.83%
% of All Funds
3.03%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.11%
New
26
Increased
46
Reduced
70
Closed
49
Calls
$41.8M
Puts
$146M
Net Calls
-$104M
Net Calls Change
-$13.9M

BHC Hedge Fund Activity: Q3 2024 in Review

211 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q3 2024, worth a combined $2.09B — up 6.4% from $1.96B a quarter earlier.

Sellers outnumbered buyers: 49 funds closed out of BHC and 26 opened new positions — a net loss of 23 holders — while 70 trimmed existing stakes and 46 added.

The largest buyer was Goldentree Asset Management, adding an estimated $45.9M. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $80.2M sold.

  • 211 institutional investors held Bausch Health (BHC) as of Q3 2024, down from 234 in Q2 2024.
  • Funds reported $2.09B of Bausch Health stock for Q3 2024, up 6.4% quarter-over-quarter.
  • 26 funds opened new Bausch Health positions in Q3 2024 and 49 closed out, a net change of -23 holders.
  • The largest Bausch Health buyer in Q3 2024 was Goldentree Asset Management, an estimated $45.9M added.
  • The largest Bausch Health seller in Q3 2024 was Hudson Bay Capital Management, an estimated $80.2M sold.

Based on aggregated 13F filings for Q3 2024.